Celgene Corp. Company Profile

Aggregated data from the web about Celgene Corp.

Company Name	Celgene Corp.
Website	https://en.wikipedia.org
Snippet	Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).
Type	Subsidiary
Parent	Bristol Myers Squibb
Founded	1986
Founder	Sol J. Barer
Revenue	$15.281 billion (2018)
Website	www.celgene.com
Industry	Biotechnology
Products	RevlimidAbraxanePomalyst/ImnovidThalomidIdhifa
Key people	Robert J. Hugin (Executive Chairman)Mark Alles (CEO)
Net income	$4.046 billion (2018)
Headquarters	Summit, New Jersey, U.S.
Total assets	$35.480 billion (2018)
Total equity	$6.161 billion (2018)
Number of employees	8,852 (2018)

Celgene Corp. is part of the United States company list

Celgene Corp. is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.